By the year 2000 - after a 12,000-year history of farming - farmers may no longer be able to save seed or breed improved varieties. The problem is not the Millennium Bug but the Millennium Seed."
Recent Content Related to Militarism & Dissent
As a result of solid NGO pressure, the ominous Terminator Technology" became a topic of substantive discussion and debate at the recent meeting of the Conference of Parties to the Convention on Biological Diversity (COP IV) in Bratislava, Slovakia, 4-15 May.
Advocates for the newly patented terminator technology" developed jointly by the US Department of Agriculture and Mississippi-based Delta and Pine Land seed company claim that it will not only be an incentive to plant breeding investment but also a boon to food production in the South. This is "nonsense" according to RAFI Research Director, Hope Shand.
After a week of silence on the subject, the USA (a country that is not a Party to the UN Convention on Biological Diversity) is lobbying hard to re-write the Friends of the Chair' report on the Terminator - a technology widely condemned by numerous CBD members. Why the sudden spurt of behind the scenes activity? On May 11th, the giant Monsanto Corporation - a company with close White House connections and major multinational muscle - bought control of the Terminator patent. For Governments fighting to protect agricultural biodiversity in the Convention, its now or never.
Monsanto, the world's second largest pesticides corporation, has vaulted from nowhere to become the world's fourth largest seed company. Between mid-1996 and the end of 1997, Monsanto spent roughly US $2 billion in seed-related acquisitions. Its May 11th announcement that the corporation will take over Dekalb and Delta and Pine Land seed companies adds a staggering US $4.3 billion to its merger bill. By way of comparison, if Monsanto's Monday splurge were spent on public sector research, it would fully fund the entire CGIAR system at 1998 levels for over 12 years. But it is not who Monsanto is buying - but what patents it is acquiring - that has observers alarmed. Monsanto now has the Terminator - and maybe much more.
Delta and Pine Land Co. (Mississippi, USA) and the U.S. Department of Agriculture (USDA) announced that they received US Patent No. 5,723,765 on a new genetic technology designed to prevent unauthorized seed saving by farmers. The patented technology, Control of plant gene expression" would allow seed companies to control the viability of progeny seed without harming the crop. In other words, the new technology genetically alters the seed so that it will not germinate if re-planted a second time.
This map illustrates the transfer of human tissues through third countries. This graphic is part of the Communique on Human Tissue Trade.
Despite the promise of medical breakthroughs, the utilization of human tissue prompts intense ethical concerns regarding ownership of human biomaterials, eugenics, discrimination and medical confidentiality. A large and growing South to North and North to North movement of human tissue is taking place in an almost total policy and regulatory vacuum.
Human Tissue Collection Initiatives by the U.S. Military; Colombian Indigenous Peoples' Cells in the U.S.; Accompanying maps showing cell collections inColombia and Papua New Guinea
RAFI warns that the Human Genome Diversity Project's outrageous proposal to collect human DNA from 722 communities around the world has serious implications for indigenous peoples. Will profits be made from the genes of poor people whose physical survival is in question? Who will have access and what benefits will accrue to indigenous communities?